intangible-adjusted valuations Tag

DM Asia Pharmaceuticals & Biotech: Worth A Second Look?

31 Mar, by Knowledge Leaders Team in Knowledge Leaders, Markets

Pharma and biotech in developed Asia has been among the region’s worst performing industry groups in the last year, but our research suggests that their recent underperformance may be somewhat overblown. Recent performance places these companies squarely in the bottom fifth of industry groups for...